Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1506609Generated: November 1, 2026

HCID 16659853, compound → HCID 178517319, compound

https://huagongshe.com/reaction/1506609

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHCID 16659853HCID 16659853—
ReactantHCID 16659855HCID 16659855—
ReactantHCID 178510096HCID 178510096—
ReactantHCID 178517321HCID 178517321—
ProductHCID 178517319HCID 178517319—

Reaction Steps

trans-3-[(8′-Chloro-2′-oxo-2′,3′-dihydro-1′H-spiro[cyclohexane-1,4′-quina-zolin]-5′-yl)oxy]cyclobutanecarboxylic acid; 3-[(8′-fluoro-2′-oxo-2′,3′-dihydro-1′H-spiro[cyclohexane-1,4′-quinazolin]-5′-yl)oxymethyl]cyclobutanecarboxylic acid; trans-3-[(8′-cyano-2′-oxo-2′,3′-dihydro-1′H-spiro[cyclohexane-1,4′-quinaz-olin]-5′-yl)oxy]cyclobutanecarboxylic acid; 1-[(8′-fluoro-2′-oxo-2′,3′-dihydro-1′H-spiro[cyclohexane-1,4′-quinazolin]-5′-yl)oxymethyl]cyclobutanecarboxylic acid; trans-3-[(8′-chloro-2′-oxo-2′,3′-dihydro-1′H-spiro[cycloheptyl-1,4′-quina-zolin]-5′-yl)oxy]cyclobutanecarboxylic acid; and trans-3-[(8′-chloro-2′-oxo-2′,3′-dihydro-1′H-spiro[cyclopentyl-1,4′-quinazolin]-5′-yl)oxy]cyclobutanecarboxylic acid; or a pharmaceutically acceptable salt, solvate, polymorph or prodrug thereof.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09220715B2
Source datasetuspto-grants-2015_12
ORD IDord-13afd7ace3cf4a28b0cee30de8814d8e
Source noteuspto-grants-2015_12